Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia
J Bertherat, I Bourdeau, L Bouys… - Endocrine …, 2023 - academic.oup.com
Patients with primary bilateral macronodular adrenal hyperplasia (PBMAH) usually present
bilateral benign adrenocortical macronodules at imaging and variable levels of cortisol …
bilateral benign adrenocortical macronodules at imaging and variable levels of cortisol …
Expanding the role of the histone lysine-specific demethylase LSD1 in cancer
Studies of alterations in histone methylation in cancer have led to the identification of histone
methyltransferases and demethylases as novel targets for therapy. Lysine-specific …
methyltransferases and demethylases as novel targets for therapy. Lysine-specific …
Global burden of multiple myeloma: a systematic analysis for the global burden of disease study 2016
Introduction Multiple myeloma (MM) is a plasma cell neoplasm with substantial morbidity
and mortality. A comprehensive description of the global burden of MM is needed to help …
and mortality. A comprehensive description of the global burden of MM is needed to help …
Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study
F Chasseloup, I Bourdeau, A Tabarin… - The lancet Diabetes & …, 2021 - thelancet.com
Background GIP-dependent primary bilateral macronodular adrenal hyperplasia with
Cushing's syndrome is caused by aberrant expression of the GIP receptor in adrenal …
Cushing's syndrome is caused by aberrant expression of the GIP receptor in adrenal …
Organoids as innovative models for bone and Joint diseases
Bone is one of the key components of the musculoskeletal system. Bone and joint disease
are the fourth most widespread disease, in addition to cardiovascular disease, cancer, and …
are the fourth most widespread disease, in addition to cardiovascular disease, cancer, and …
Primary bilateral macronodular adrenal hyperplasia: definitely a genetic disease
IP Cavalcante, A Berthon, MC Fragoso… - Nature Reviews …, 2022 - nature.com
Primary bilateral macronodular adrenal hyperplasia (PBMAH) is an adrenal cause of
Cushing syndrome. Nowadays, a PBMAH diagnosis is more frequent than previously, as a …
Cushing syndrome. Nowadays, a PBMAH diagnosis is more frequent than previously, as a …
Epidemiology, genetics and treatment of multiple myeloma and precursor diseases
K Hemminki, A Försti, R Houlston… - International journal of …, 2021 - Wiley Online Library
Multiple myeloma (MM) is a hematological malignancy caused by the clonal expansion of
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …
plasma cells. The incidence of MM worldwide is increasing with greater than 140 000 …
Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk
Estimating familial cancer risks is clinically important in being able to discriminate between
individuals in the population at differing risk for malignancy. To gain insight into the familial …
individuals in the population at differing risk for malignancy. To gain insight into the familial …
KDM1A inactivation causes hereditary food-dependent Cushing syndrome
A Vaczlavik, L Bouys, F Violon, G Giannone… - Genetics in …, 2022 - Elsevier
Purpose This study aimed to investigate the genetic cause of food-dependent Cushing
syndrome (FDCS) observed in patients with primary bilateral macronodular adrenal …
syndrome (FDCS) observed in patients with primary bilateral macronodular adrenal …
Genome instability in multiple myeloma: Facts and factors
Simple Summary Multiple myeloma is an incurable blood cancer caused by the malignant
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …
transformation of immunoglobulin-producing plasma cells. The mechanisms leading to the …